Johnson & Johnson vs Tilray Brands, Inc. — Stock Comparison
Q·Score Breakdown
7.1
Bullish
Overall
4.4
Bearish
Quality
Health
Growth
Valuation
Sentiment
JNJ
High-quality business with 26% return on equity and 22% profit margins.
⚠ earnings contracting 53% year-over-year.
TLRY
Consensus analyst target of $10.04 is 63% above current price.
⚠ currently unprofitable (-157% margin).
Analyst Consensus
BUY
Target $252.42 (+11.1%)
24 analysts
HOLD
Target $10.04 (+63.1%)
9 analysts
Fundamentals
JNJ
TLRY
26.3×
Trailing P/E
—
17.9×
Forward P/E
22.7×
21.8%
Profit Margin
-156.7%
68.0%
Gross Margin
27.7%
26.4%
ROE
-63.2%
9.9%
Revenue Growth
-7.8%
-52.9%
Earnings Growth
—
0.33
Beta
2.11
—
Price / Book
—
$546.9B
Market Cap
$737M
$146 – $252
52-Week Range
$4 – $23
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →